A blood exchange lowered blood fats in one infant whose levels exceeded 200 times the upper normal limit. The 2026 report in JCEM Case Reports described a rare inherited condition. The infant lacked lipoprotein lipase, a protein that helps break down blood fats. This is **not the same as Lipase**, the pancreas enzyme tracked in this community. The baby had bleeding in the digestive tract and needed intensive care. Blood flow was poor, though the body was still partly making up for it. The blood’s fatty appearance gave the care team an early clue. Genetic testing later confirmed the condition. Triglycerides, a type of blood fat, peaked above 200 times the upper normal limit. Insulin given through a vein did not help. A whole-blood exchange—replacing the baby’s blood with donor blood—led to a lasting drop. Despite the extreme blood fat levels, the report described little organ damage. This was one case, not proof of a best treatment. The authors noted that urgent treatment lacks a standard approach. Whether such intensive treatment is always needed remains unclear. Long-term care for this inherited condition centers on strict food choices. For this community, the key tracking lesson is to keep these measurements separate. This report does not show how blood exchange affects Lipase. It also cannot explain a member’s own high or low result. When comparing numbers here, including the exact test name, units, and lab range helps avoid mixing up different tests. What have you learned from comparing your Lipase results and lab ranges over time?